Ahmc Anaheim Regional Medical

Ahmc Anaheim Regional Medical was paid $14.21M by Medicaid between Jan 2018 and Dec 2024, across 291 billing codes. Its largest line is 0450, Emergency room services — 8.6% of everything it billed.

33Billing provider infoAHMC ANAHEIM REGIONAL MEDICAL
ANAHEIM, CA 92801

33aNPI1891938122assigned 04/16/2009

33bProvider typeGeneral Acute Care Hospital

28Total paid$14.21M

24GClaims1,105,431

24DCodes billed291

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#157 of 410

Median peer was paid$6.90M

This provider vs. median2.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MARSH, LINDA controls 11+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	197,082	$1.75M
2019	171,922	$2.05M
2020	150,882	$1.89M
2021	141,003	$1.40M
2022	155,684	$1.72M
2023	165,105	$2.44M
2024incomplete	123,753	$2.96M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	8.6%	76,097	65,701	$1.22M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	5.7%	17,374	10,073	$807K
74176	Computed tomography, abdomen and pelvis; without contrast material	4.3%	6,926	6,169	$617K
74177	Computed tomography, abdomen and pelvis; with contrast material	3.8%	3,525	3,108	$540K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	3.4%	9,412	7,911	$479K
70450	Computed tomography, head or brain; without contrast material	3.3%	9,701	8,843	$472K
93458		2.9%	522	467	$411K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.9%	15,131	12,963	$407K
J3490	Unclassified drugs	2.8%	71,314	26,807	$402K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.6%	27,461	23,614	$371K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	2.6%	10,469	9,413	$363K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	2.4%	9,720	8,198	$345K

279 more codes

96375	Therapeutic injection; each additional sequential IV push	2.2%	11,926	$307K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.1%	5,613	$302K
Z7502		1.9%	7,023	$264K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.7%	52,775	$237K
71045	Radiologic examination, chest; single view	1.7%	26,298	$236K
83880		1.6%	11,878	$224K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.5%	10,980	$210K
80048	Basic metabolic panel (calcium, ionized)	1.4%	40,902	$198K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.4%	6,743	$195K
0270		1.3%	91,032	$183K
71275	Computed tomographic angiography, chest, with contrast material	1.1%	898	$151K
J7030	Infusion, normal saline solution , 1000 cc	1.1%	25,117	$150K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,876	$138K
84484		<1%	21,885	$127K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,420	$125K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	4,732	$124K
J1815	Injection, insulin, per 5 units	<1%	2,499	$116K
99199	Unlisted special service, procedure or report	<1%	1,966	$111K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,456	$110K
93971		<1%	1,414	$110K
96361	Intravenous infusion, hydration; each additional hour	<1%	4,994	$105K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	845	$104K
80076		<1%	24,835	$101K
80053	Comprehensive metabolic panel	<1%	13,411	$91K
S3620	Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)	<1%	607	$89K
A4217	Sterile water/saline, 500 ml	<1%	13,739	$84K
76830	Ultrasound, transvaginal	<1%	1,700	$83K
83690		<1%	19,569	$82K
93970		<1%	767	$82K
L8699	Prosthetic implant, not otherwise specified	<1%	369	$81K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,811	$81K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,612	$80K
88312		<1%	1,630	$78K
76801		<1%	1,640	$78K
0272		<1%	10,486	$76K
Z7610		<1%	4,435	$70K
99283	Emergency room visit (moderate)	<1%	6,033	$68K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	6,482	$63K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,095	$60K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	719	$60K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	9,037	$59K
J2785	Injection, regadenoson, 0.1 mg	<1%	437	$57K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,654	$57K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	12,698	$57K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,840	$55K
Z9725		<1%	1,230	$53K
99285	Emergency room visit (most serious)	<1%	1,150	$52K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	268	$51K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,935	$51K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,240	$50K
80305		<1%	6,072	$49K
90715		<1%	1,843	$48K
99284	Emergency room visit (serious)	<1%	1,827	$47K
87040		<1%	5,155	$45K
71046	Radiologic examination, chest; 2 views	<1%	3,375	$45K
83605		<1%	6,649	$44K
85730		<1%	13,693	$42K
81001		<1%	23,308	$42K
87086	Culture, bacterial; quantitative colony count, urine	<1%	9,237	$40K
77065	Tomosynthesis, mammo	<1%	658	$37K
0360		<1%	9,933	$37K
Z7500		<1%	1,054	$36K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,484	$36K
85610		<1%	16,733	$35K
81025		<1%	13,328	$34K
76641		<1%	646	$34K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,279	$33K
77066	Tomosynthesis, mammo	<1%	308	$33K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	482	$32K
0710		<1%	8,729	$31K
73562		<1%	2,051	$31K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	7,063	$28K
72100		<1%	1,439	$28K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	185	$28K
73630		<1%	1,867	$28K
70486		<1%	386	$28K
84702		<1%	3,738	$27K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	4,256	$26K
73030		<1%	1,703	$26K
59025	Fetal non-stress test	<1%	1,599	$26K
78454		<1%	482	$25K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	64	$24K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	7,705	$24K
73610		<1%	1,517	$23K
0160		<1%	1,569	$23K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	6,400	$22K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,752	$22K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	135	$22K
73130		<1%	1,523	$21K
81003		<1%	18,459	$21K
88313		<1%	1,682	$21K
99070		<1%	1,223	$20K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,615	$19K
82962		<1%	9,822	$18K
J0690	Injection, cefazolin sodium, 500 mg	<1%	3,268	$17K
76942		<1%	754	$17K
C1769	Guide wire	<1%	662	$17K
0250		<1%	17,018	$16K
85379		<1%	2,397	$16K
J1644	Injection, heparin sodium, per 1000 units	<1%	4,397	$15K
83735		<1%	4,451	$15K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	717	$15K
93017		<1%	481	$15K
G0378	Hospital observation service, per hour	<1%	152	$14K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	1,335	$14K
82550		<1%	3,183	$13K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,800	$13K
84443	Thyroid stimulating hormone (TSH)	<1%	1,460	$13K
72040		<1%	692	$12K
36415	Collection of venous blood by venipuncture	<1%	5,972	$12K
87186		<1%	2,488	$11K
73110		<1%	709	$11K
76937		<1%	745	$11K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	974	$11K
J2060	Injection, lorazepam, 2 mg	<1%	2,392	$10K
76642		<1%	236	$10K
85027		<1%	2,919	$9K
74018		<1%	656	$9K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,234	$9K
87088		<1%	2,616	$9K
96367		<1%	293	$9K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	39	$8K
71250		<1%	84	$8K
94664		<1%	4,158	$8K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	951	$8K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	309	$7K
87070		<1%	1,699	$7K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	420	$7K
36430		<1%	165	$7K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,039	$7K
73502		<1%	376	$6K
99292		<1%	43	$6K
72131		<1%	68	$6K
86901		<1%	3,495	$6K
83874		<1%	1,126	$6K
86900		<1%	3,492	$6K
82150		<1%	1,339	$6K
86920		<1%	289	$5K
82553		<1%	781	$5K
73590		<1%	387	$5K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,206	$5K
87631		<1%	108	$5K
71010		<1%	324	$5K
87077		<1%	1,252	$5K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	333	$5K
85007		<1%	2,722	$4K
88304		<1%	788	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	286	$4K
J2704	Injection, propofol, 10 mg	<1%	1,549	$4K
94760		<1%	1,345	$4K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	284	$4K
0762		<1%	1,033	$4K
74022		<1%	247	$4K
J7050	Infusion, normal saline solution, 250 cc	<1%	1,862	$4K
0258		<1%	2,724	$4K
80061	Lipid panel	<1%	589	$4K
84703		<1%	1,140	$3K
86850		<1%	2,148	$3K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	262	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,078	$3K
87081		<1%	1,238	$3K
12001		<1%	242	$3K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	34	$3K
82010		<1%	505	$3K
J3370	Injection, vancomycin hcl, 500 mg	<1%	338	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	770	$3K
93975		<1%	16	$3K
94060		<1%	120	$3K
83036	Hemoglobin; glycosylated (A1C)	<1%	515	$3K
87807		<1%	729	$3K
73070		<1%	207	$2K
71101		<1%	147	$2K
82805		<1%	178	$2K
94729		<1%	106	$2K
70496		<1%	17	$2K
47563		<1%	14	$2K
94726		<1%	95	$2K
87147		<1%	645	$2K
93041		<1%	1,807	$2K
82040		<1%	875	$2K
96376		<1%	586	$2K
88307		<1%	95	$2K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	249	$1K
10060		<1%	124	$1K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	2,544	$1K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	652	$1K
99000		<1%	369	$1K
86140		<1%	401	$1K
36569		<1%	22	$1K
76770		<1%	28	$1K
97750		<1%	49	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	192	$1K
47562		<1%	12	$1K
84100		<1%	417	$1K
71020		<1%	36	$1K
82375		<1%	176	$1K
84132		<1%	541	$978.66
29881		<1%	13	$950.00
96368		<1%	100	$888.75
82140		<1%	109	$869.70
29125		<1%	296	$852.93
94761		<1%	26	$838.02
96379		<1%	161	$835.23
49083		<1%	43	$825.61
J2720	Injection, protamine sulfate, per 10 mg	<1%	99	$797.88
73140		<1%	80	$767.35
73080		<1%	32	$660.82
J1940	Injection, furosemide, up to 20 mg	<1%	183	$652.36
J3411	Injection, thiamine hcl, 100 mg	<1%	138	$637.29
J1650	Injection, enoxaparin sodium, 10 mg	<1%	98	$631.99
C1760	Closure device, vascular (implantable/insertable)	<1%	13	$631.16
84439		<1%	170	$611.56
0459		<1%	852	$584.72
83050		<1%	163	$563.82
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	28	$548.70
12011		<1%	72	$504.97
75820		<1%	13	$504.89
76870		<1%	16	$496.36
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	79	$453.13
73090		<1%	39	$430.43
88173		<1%	37	$420.86
10022		<1%	37	$415.33
29515		<1%	120	$404.18
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	<1%	38	$401.68
0760		<1%	1,379	$363.97
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	12	$325.08
J0456	Injection, azithromycin, 500 mg	<1%	38	$300.12
94618		<1%	55	$296.49
0750		<1%	682	$274.20
0301		<1%	1,260	$250.43
74000		<1%	19	$248.20
51702		<1%	43	$246.32
97116		<1%	42	$244.05
82248		<1%	84	$224.68
76000		<1%	16	$222.41
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	20	$189.77
36600		<1%	71	$160.55
0402		<1%	107	$138.77
J9999	Not otherwise classified, antineoplastic drugs	<1%	18	$121.99
73620		<1%	13	$117.93
85018		<1%	166	$102.75
J2470	Injection, pantoprazole sodium, 40 mg	<1%	37	$95.88
J0780	Injection, prochlorperazine, up to 10 mg	<1%	19	$79.89
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	262	$77.53
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	28	$73.05
0271		<1%	105	$58.47
87210		<1%	26	$58.24
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	13	$50.43
81002		<1%	85	$44.33
J3480	Injection, potassium chloride, per 2 meq	<1%	108	$28.92
86308		<1%	13	$28.72
84550		<1%	14	$25.68
C9399	Unclassified drugs or biologicals	<1%	234	$25.26
0636		<1%	516	$17.66
0306		<1%	492	$15.70
0305		<1%	657	$12.28
J1630	Injection, haloperidol, up to 5 mg	<1%	13	$11.47
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	50	$9.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	41	$8.68
85651		<1%	13	$7.85
C9290	Injection, bupivacaine liposome, 1 mg	<1%	155	$5.96
0307		<1%	153	$5.02
29130		<1%	14	$1.99
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	0%	174	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	15	$0.00
0361		0%	96	$0.00
G9656	Patient transferred directly from anesthetizing location to pacu or other non-icu location	0%	285	$0.00
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	0%	13	$0.00
99215	Doctor's office visit, returning patient (complex)	0%	286	$0.00
0302		0%	53	$0.00
0351		0%	68	$0.00
0320		0%	301	$0.00
0300		0%	71	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	17	$0.00
0370		0%	668	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	15	$0.00
0720		0%	1,067	$0.00
0350		0%	86	$0.00
0310		0%	75	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARSH, LINDA (SENIOR VICE PRESIDENT)

Same official

Other billing entities under MARSH, LINDA

Full network →

Provider	Location	Paid
Ahmc Garfield Medical Center LP	Monterey Park, CA	$17.83M
Ahmc Whittier Hospital Medical	Whittier, CA	$15.12M
Ahmc Monterey Park Hospital LP	Monterey Park, CA	$10.85M
Ahmc Greater El Monte Community	South El Monte, CA	$9.17M
Ahmc San Gabriel Valley Medical	San Gabriel, CA	$6.96M
Alhambra Hospital Medical Center, LP	Alhambra, CA	$6.90M
Ahmc Seton Medical Center LLC	Daly City, CA	$5.21M
Alhambra Hospital Medical Center, LP	Alhambra, CA	$1.57M
Ahmc San Gabriel Valley Medical	San Gabriel, CA	$249K
Alhambra Hospital Medical Center, LP	Alhambra, CA	$176K
Alhambra Hospital Medical Center, LP	Alhambra, CA	$34K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.